Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
1.180
-0.070 (-5.60%)
At close: Nov 6, 2025, 4:00 PM EST
1.200
+0.020 (1.69%)
After-hours: Nov 6, 2025, 5:11 PM EST
Outlook Therapeutics Market Cap
Outlook Therapeutics has a market cap or net worth of $52.42 million as of November 6, 2025. Its market cap has decreased by -61.06% in one year.
Market Cap
52.42M
Enterprise Value
78.21M
1-Year Change
-61.06%
Ranking
Category
Stock Price
$1.18
Market Cap Chart
Since June 14, 2016, Outlook Therapeutics's market cap has decreased from $97.37M to $52.42M, a decrease of -46.17%. That is a compound annual growth rate of -6.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 55.52M | 17.96% |
| Dec 31, 2024 | 47.07M | -54.10% |
| Dec 29, 2023 | 102.54M | -63.01% |
| Dec 30, 2022 | 277.20M | -9.11% |
| Dec 31, 2021 | 304.99M | 84.47% |
| Dec 31, 2020 | 165.34M | 630.93% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jun 14, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 811.99B |
| Johnson & Johnson | 450.20B |
| AbbVie | 381.56B |
| UnitedHealth Group | 299.68B |
| AstraZeneca | 253.45B |
| Novartis AG | 240.68B |
| Abbott Laboratories | 218.75B |
| Novo Nordisk | 215.64B |